In this confirmatory study, we tested if a calculation that included the non-uniformity of dose deposition through a voxel-based dosimetric variable Ψ was able to improve the dose–re-sponse agreement with respect to the mean absorbed dose D. We performed dosimetry with99mTc-MAA SPECT/CT and90Y-PET/CT in 86 patients treated 8 instead of 4 days after the reference date with 2.8 times more90Y glass microspheres/GBq than in our previous study. The lesion-by-lesion response was assessed with the mRECIST method and with an experimental densitometric crite-rion. A total of 106 lesions were studied. Considering Ψ as a prognostic response marker, having no Ψ provided a significantly higher AUC than D. The correlation, t-test, and AUC values were statis-tically significant only with the densitometric method and only with post-therapy dosimetry. In comparison with our previous study, the dose–response correlation and AUC values were poorer (maximum r = 0.43, R2 = 0.14, maximal AUC = 0.71), and the efficacy at a high dose did not reach 100%. The expected advantages of voxel dosimetry were nullified by the correlation between any Ψ and D due to the limited image spatial resolution. The lower AUC and efficacy may be explained by the mega-clustering effect triggered by the higher number of microspheres/GBq injected on day 8.
Radioembolization of Hepatocellular Carcinoma with90Y Glass Microspheres: No Advantage of Voxel Dosimetry with Respect to Mean Dose in Dose–Response Analysis with Two Radiological Methods / C. Romano, S. Mazzaglia, M. Maccauro, C. Spreafico, A. Gabutti, G. Maffi, C. Morosi, T. Cascella, M. Mira, M.C. De Nile, G. Aliberti, G. Argiroffi, V. Fuoco, S. Bhoori, C. Zanette, A. Marchiano, E. Seregni, V. Mazzaferro, C. Chiesa. - In: CANCERS. - ISSN 2072-6694. - 14:4(2022), pp. 959.1-959.27. [10.3390/cancers14040959]
Radioembolization of Hepatocellular Carcinoma with90Y Glass Microspheres: No Advantage of Voxel Dosimetry with Respect to Mean Dose in Dose–Response Analysis with Two Radiological Methods
V. MazzaferroPenultimo
;
2022
Abstract
In this confirmatory study, we tested if a calculation that included the non-uniformity of dose deposition through a voxel-based dosimetric variable Ψ was able to improve the dose–re-sponse agreement with respect to the mean absorbed dose D. We performed dosimetry with99mTc-MAA SPECT/CT and90Y-PET/CT in 86 patients treated 8 instead of 4 days after the reference date with 2.8 times more90Y glass microspheres/GBq than in our previous study. The lesion-by-lesion response was assessed with the mRECIST method and with an experimental densitometric crite-rion. A total of 106 lesions were studied. Considering Ψ as a prognostic response marker, having no Ψ provided a significantly higher AUC than D. The correlation, t-test, and AUC values were statis-tically significant only with the densitometric method and only with post-therapy dosimetry. In comparison with our previous study, the dose–response correlation and AUC values were poorer (maximum r = 0.43, R2 = 0.14, maximal AUC = 0.71), and the efficacy at a high dose did not reach 100%. The expected advantages of voxel dosimetry were nullified by the correlation between any Ψ and D due to the limited image spatial resolution. The lower AUC and efficacy may be explained by the mega-clustering effect triggered by the higher number of microspheres/GBq injected on day 8.| File | Dimensione | Formato | |
|---|---|---|---|
|
Radioembolization of Hepatocellular Carcinoma.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
3.81 MB
Formato
Adobe PDF
|
3.81 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.




